

Ep. 216 - Anti-China Biotech Policy: Biosecure & Beyond
Feb 16, 2024
CEOs of U.S. biotechs fear losing access to Chinese CDMOs. Legislation could impact collaboration with Chinese companies. BIO warns bills would negatively affect U.S. biotech ecosystem. Analysis of implications and concerns surrounding anti-China biotech policy in Washington.
Chapters
Transcript
Episode notes